Elicio Therapeutics (ELTX) Assets Average (2021 - 2026)

Elicio Therapeutics (ELTX) has reported Assets Average for 6 consecutive years, with $27.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average fell 6.33% year-over-year to $27.0 million; the trailing twelve-month figure through Jun 2026 stood at $27.0 million (down 6.33% YoY), and the FY2025 full-year result was $27.0 million, down 2.32% from the prior year.
• Assets Average climbed to $27.0 million in Q2 2026 per ELTX's latest filing, from $24.3 million in the prior quarter.
• Across five years, Assets Average topped out at $88.9 million in Q1 2022 and bottomed at $20.1 million in Q2 2024.
• Historically, Assets Average has averaged $37.7 million across 5 years, with a median of $29.0 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Assets Average plunged 63.76% in 2023, then jumped 43.36% in 2025.
• Over 5 years, Assets Average stood at $42.0 million in 2022, then plunged by 30.78% to $29.1 million in 2023, then climbed by 14.51% to $33.3 million in 2024, then slipped by 18.66% to $27.1 million in 2025, then slipped by 0.23% to $27.0 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $27.0 million, $24.3 million, and $27.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.